Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?
Author:
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1038/bjp.2008.297/fullpdf
Reference12 articles.
1. Soft drug design: general principles and recent applications;Bodor;Med Res Rev,2000
2. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one];Boswell-Smith;J Pharmacol Exp Ther,2006
3. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma;Evans;N Engl J Med,1997
4. Phosphodiesterase 4: Selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease;Giembycz;Proc Am Thor Soc,2005
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats;International Immunopharmacology;2023-04
2. Neuroprotective effect of roflumilast under cerebral ischaemia/reperfusion injury in juvenile rats through NLRP‐mediated inflammatory response inhibition;Clinical and Experimental Pharmacology and Physiology;2021-05-10
3. Roflumilast: A potential drug for the treatment of cognitive impairment?;Neuroscience Letters;2020-09
4. Advances in the Development of Phosphodiesterase-4 Inhibitors;Journal of Medicinal Chemistry;2020-04-07
5. Impact of Phosphodiesterase 4 Inhibition on the Operational Efficacy, Response Maxima, and Kinetics of Indacaterol-Induced Gene Expression Changes in BEAS-2B Airway Epithelial Cells: A Global Transcriptomic Analysis;Molecular Pharmacology;2019-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3